Navigation Links
DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Date:3/19/2013

New York, NY (PRWEB) March 19, 2013

The prescription drug resource center DrugRisk.com is alerting patients who have taken the drug Actos of updated legal news on the site. The resource site learned this week of new evidence showing the manufacturer may have known of the risks of bladder cancer in 2003, but did nothing to warn patients.

“The goal of DrugRisk is to improve consumer safety by publishing the latest drug warnings, recalls, studies and litigation news. Informed patients can discuss options with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

The resource center contains Actos warnings from both the FDA* and European Medicines Agency** who indicated that long-term use of the drug may be associated with an increased risk of bladder cancer. The drug has also been banned in France and Germany.***

In legal news, Takeda, the maker of Actos faces as many as 3,000 claims over Actos bladder cancer.**** More than 1,200 patients have filed an Actos lawsuit against the drug maker in a special multi-district federal court in Louisiana.***** Other cases have been filed in California.****

The first Actos trial began this month in California. Now, DrugRisk has learned that lawyers representing a man dying of cancer in that trial filed a study on January 25th which shows Takeda asked doctors in 2003 if they would still prescribe a diabetes drug that had bladder cancer risks. However, they didn’t disclose their concerns to patients.****

Lawyers are still helping those affected file claims. Anyone diagnosed with bladder cancer after taking Actos is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of defective drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

For more information on the research, side effects, litigation news and a potential Actos recall or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos
**http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail_001311.jsp&mid=WC0b01ac058004d5c1
***cbsnews.com/8301-504763_162-20070492-10391704.html
****businessweek.com/news/2013-02-15/takeda-worried-about-actos-s-cancer-link-filing-shows
***** In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

Read the full story at http://www.prweb.com/releases/actos-recall/actos-lawsuits/prweb10491110.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
2. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
3. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
4. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
5. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
6. DrugRisk Announces New Pradaxa Health Warning From Australia
7. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
8. DrugRisk Announces Updated Information on Mirena Lawsuits
9. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
10. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
11. Update: Number of Stryker Rejuvenate Hip Recall Lawsuits Growing in New Jersey Multicounty Litigation, Announces Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... ... Winner for its Product Innovation in the prestigious CEO World Awards®. The coveted ... performance, new products and services, CEO case studies, corporate social responsibility, and milestones ...
(Date:7/25/2017)... ... July 25, 2017 , ... SignatureCare Emergency Center – South Austin is ... 24 Hours a day. , The Emergency Room opened early March, ... open four months now and things are running smoothly,” said Aaron Braun, SignatureCare Emergency ...
(Date:7/24/2017)... PARK (PRWEB) , ... July 24, 2017 , ... Engineers ... is bio-compatible, because it produces the same kind of electrical energy that the body ... the form of moving electrons. This flow of electrons out of the battery is ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... kklaproth(at)robinsmorton(dot)com , Robins & Morton, Perkins Will, Newcomb & Boyd, Walter P ... of the new Destination Medical Building located at Mayo Clinic in Jacksonville, ...
(Date:7/24/2017)... ... July 24, 2017 , ... Cheerag D. Upadhyaya , ... Marion Bloch Neuroscience Institute (SLMBNI), part of Saint Luke’s Health System . ... , Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins Stanley P. Fisher, M.D., ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... July 21, 2017  Endo International plc (NASDAQ: ... comprehensive review of its manufacturing network, the Company will ... facilities in Huntsville, Alabama . The ... over the next 12 to 18 months. The ... declining volumes of commoditized products and these restructuring actions ...
(Date:7/19/2017)... , July 19, 2017  Mako Medical Laboratories partnered ... the Military Family Assistance Fund (MFA) to bring 140 ... to visit with their families one last time before ... coordinate the travel and logistics needed for these soldiers. ... soldiers and their families. We just wish we could ...
(Date:7/14/2017)... -- Endo International plc (NASDAQ: ENDP ) will announce ... of its senior management team will host a conference call and ... The dial-in number to access the call is ... the passcode is 45397076. Please dial in 10 minutes prior to ... A replay of the call will be available from August 8, ...
Breaking Medicine Technology: